509 related articles for article (PubMed ID: 32247604)
21. Combination of sentinel lymph node mapping and uterine frozen section examination to reduce side-specific lymphadenectomy rate in endometrial cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002).
Altin D; Taşkın S; Kahramanoglu I; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Naki MM; Güngör M; Köse MF; Ortac F; Arvas M; Ayhan A; Taskiran C
Int J Gynecol Cancer; 2020 Jul; 30(7):1005-1011. PubMed ID: 32474451
[TBL] [Abstract][Full Text] [Related]
22. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.
Chi DS; Barakat RR; Palayekar MJ; Levine DA; Sonoda Y; Alektiar K; Brown CL; Abu-Rustum NR
Int J Gynecol Cancer; 2008; 18(2):269-73. PubMed ID: 18334008
[TBL] [Abstract][Full Text] [Related]
23. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.
Ducie JA; Eriksson AGZ; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Soslow RA; Keeney GL; Abu-Rustum NR; Mariani A; Leitao MM
Gynecol Oncol; 2017 Dec; 147(3):541-548. PubMed ID: 28965698
[TBL] [Abstract][Full Text] [Related]
24. Sentinel Nodal Metastasis Detection in Endometrial Carcinoma With Microcystic, Elongated, and Fragmented (MELF) Pattern by Cytokeratin Immunostaining.
Rabe KM; Klein ME; Ghatak S; Stout I; Schefter A; Erickson BK; Khalifa MA
Am J Clin Pathol; 2021 Oct; 156(5):846-852. PubMed ID: 34125164
[TBL] [Abstract][Full Text] [Related]
25. Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma.
St Clair CM; Eriksson AG; Ducie JA; Jewell EL; Alektiar KM; Hensley ML; Soslow RA; Abu-Rustum NR; Leitao MM
Ann Surg Oncol; 2016 May; 23(5):1653-9. PubMed ID: 26714954
[TBL] [Abstract][Full Text] [Related]
26. A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial).
Grassi T; Mariani A; Cibula D; Soliman PT; Suman VJ; Weaver AL; Pedra Nobre S; Weigelt B; Glaser GE; Cappuccio S; Abu-Rustum NR
Int J Gynecol Cancer; 2020 Oct; 30(10):1627-1632. PubMed ID: 32699021
[TBL] [Abstract][Full Text] [Related]
27. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.
Soliman PT; Westin SN; Dioun S; Sun CC; Euscher E; Munsell MF; Fleming ND; Levenback C; Frumovitz M; Ramirez PT; Lu KH
Gynecol Oncol; 2017 Aug; 146(2):234-239. PubMed ID: 28528918
[TBL] [Abstract][Full Text] [Related]
28. Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer.
Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Plante M
Gynecol Oncol; 2017 Dec; 147(3):549-553. PubMed ID: 28942993
[TBL] [Abstract][Full Text] [Related]
29. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
[TBL] [Abstract][Full Text] [Related]
30. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer.
Baiocchi G; Mantoan H; Kumagai LY; Gonçalves BT; Badiglian-Filho L; de Oliveira Menezes AN; Faloppa CC; De Brot L; da Costa AABA
Ann Surg Oncol; 2017 Dec; 24(13):3981-3987. PubMed ID: 29058141
[TBL] [Abstract][Full Text] [Related]
31. Oncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: An international multi-institutional study.
Ghoniem K; Larish AM; Dinoi G; Zhou XC; Alhilli M; Wallace S; Wohlmuth C; Baiocchi G; Tokgozoglu N; Raspagliesi F; Buda A; Zanagnolo V; Zapardiel I; Jagasia N; Giuntoli R; Glickman A; Peiretti M; Lanner M; Chacon E; Di Guilmi J; Pereira A; Laas E; Fishman A; Nitschmann CC; Parker S; Joehlin-Price A; Lees B; Covens A; De Brot L; Taskiran C; Bogani G; Paniga C; Multinu F; Hernandez-Gutierrez A; Weaver AL; McGree ME; Mariani A
Gynecol Oncol; 2021 Sep; 162(3):590-598. PubMed ID: 34274133
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics.
Marchocki Z; Cusimano MC; Clarfield L; Kim SR; Fazelzad R; Espin-Garcia O; Bouchard-Fortier G; Rossi EC; Stewart KI; Soliman PT; How JA; Gotlieb WH; Holloway RW; Ianieri MM; Cabrera S; Lim YK; Ferguson SE
Am J Obstet Gynecol; 2021 Oct; 225(4):367.e1-367.e39. PubMed ID: 34058168
[TBL] [Abstract][Full Text] [Related]
33. Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma.
Han G; Lim D; Leitao MM; Abu-Rustum NR; Soslow RA
Histopathology; 2014 Feb; 64(3):389-98. PubMed ID: 24215212
[TBL] [Abstract][Full Text] [Related]
34. Retrospective validation of the laparoscopic ICG SLN mapping in patients with grade 3 endometrial cancer.
Papadia A; Gasparri ML; Radan AP; Stämpfli CAL; Rau TT; Mueller MD
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1385-1393. PubMed ID: 29691646
[TBL] [Abstract][Full Text] [Related]
35. Accuracy of robotic sentinel lymph node detection (RSLND) for patients with endometrial cancer (EC).
Desai PH; Hughes P; Tobias DH; Tchabo N; Heller PB; Dise C; Slomovitz BM
Gynecol Oncol; 2014 Nov; 135(2):196-200. PubMed ID: 25175452
[TBL] [Abstract][Full Text] [Related]
36. Predictors of non-sentinel lymph node (non-SLN) metastasis in patients with sentinel lymph node (SLN) metastasis in endometrial cancer.
Touhami O; Trinh XB; Gregoire J; Sebastianelli A; Renaud MC; Grondin K; Plante M
Gynecol Oncol; 2015 Jul; 138(1):41-5. PubMed ID: 25891803
[TBL] [Abstract][Full Text] [Related]
37. The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia.
Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Grondin K; Plante M
Gynecol Oncol; 2018 Mar; 148(3):485-490. PubMed ID: 29290489
[TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
[TBL] [Abstract][Full Text] [Related]
39. Nodal metastasis in endometrial cancer.
Willis G; Misas JE; Byrne W; Podczaski E
Eur J Gynaecol Oncol; 2011; 32(3):259-63. PubMed ID: 21797112
[TBL] [Abstract][Full Text] [Related]
40. Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.
Schlappe BA; Weaver AL; Ducie JA; Eriksson AGZ; Dowdy SC; Cliby WA; Glaser GE; Soslow RA; Alektiar KM; Makker V; Abu-Rustum NR; Mariani A; Leitao MM
Gynecol Oncol; 2018 Nov; 151(2):235-242. PubMed ID: 30177461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
